PURPOSEFUL INNOVATION
Our Innovation Strategy
Innovation at Pharmazac is practical, focused and market-driven.
Our strategy is not based on innovation for its own sake, but on identifying product opportunities that can create real value for patients, partners and healthcare systems.
We focus on projects where scientific development, regulatory feasibility and commercial potential come together. This allows us to invest our resources in products with a clear purpose and a realistic path to market.
"As of 2025, 50% of our R&D budget will be channeled in exploring innovative generics and smart products that increase efficiency, patient compliance and therapeutic results"
(Corporate Development Report, 2025)
NEXT-GENERATION PROJECTS
Our Innovative Projects
Pharmazac’s innovative projects are selected with a clear focus on differentiation and long-term value. These projects may involve new combinations, improved formulations, alternative dosage forms or technically challenging developments that can strengthen our portfolio and create new business opportunities. Our teams evaluate each project carefully, balancing scientific complexity, development timelines, regulatory requirements and market potential.
As part of our Pharmazac50 strategic plan, taking us to our 50th anniversary in 2036, we have developed an ambitious pipeline of supra generics, including the delivery of CNS solutions in Nasal Sprays formulations and the expansion of our fixed-dose products towards innovative formulations that provide better efficacy and patient compliance.
